Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
---|---|---|---|---|---|---|
IKT | Inhibikase Therapeutics, Inc. | Director | $199K | +$199K | Oct 21, 2024 | |
RYZB | RayzeBio, Inc. | Chief Financial Officer | $0 | Feb 26, 2024 |
Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
---|